Cardiac Biomarkers Market Value Expected to Reach US$ 11.6 Billion By 2018-2024by Rahul Rastogi Market Research Analyst
According to the latest report by IMARC Group titled, “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market reached a value of US$ 6.9 Billion 2018. Looking forward, the global cardiac biomarkers market size is expected to reach a value of US$ 11.6 Billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.
Cardiac biomarkers help as risk stratification for various cardiovascular diseases including myocardial infraction, congestive heart failure, and acute coronary syndrome.
major reason associated with this sharp rise in the demand for cardiac
biomarkers is the increasing number of patients suffering from acute coronary
syndrome across the globe. Other factors include continual technological
advancements in the development of cardiovascular biomarkers, introduction of
new product launches by the companies, rise in demand for point-of-care cardiac
testing kits and high-specificity and -sensitivity of these biomarkers in
detecting cardiovascular diseases, especially acute myocardial infarction.
Apart from this, there has been a high degree of investments by numerous
private and public organizations in the R&D activities to develop advanced
technologies in the field of cardiac biomarkers.
Request a Free Sample Research Report: https://www.imarcgroup.com/request?type=report&id=1178&flag=B
Breakup by Type
- Troponins (T and I)
- Myocardial Muscle Creatine Kinase (CK-MB)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
Breakup by Location of Testing
- Laboratory Testing
- Point of Care Testing
Breakup by Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
Breakup by Region
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Key highlights of the report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Competitive Structure
- Profiles of Key Players
Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/cardiac-biomarkers-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Tel No:(D) +91 120 433 0800 | www.imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331
It’s Press Release News Published by IMARC Group
Created on Mar 12th 2019 06:00. Viewed 214 times.